Fosaprepitant
NDC 68001-675, Fosaprepitant, injection, powder, lyophilized, for solution, from BluePoint Laboratories.
- Product NDC
- 68001-675
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209965
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-675 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FOSAPREPITANT DIMEGLUMINE150 mg/5mL
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-675-25 | 68001067525 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-675-25) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ad89825f-aa31-469f-9685-159a4524dfdcMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68001-675
Use it
Look up 68001-675 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-675 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-675. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.